Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequential hybrid ablation vs. surgical CryoMaze alone for treatment of atrial fibrillation: results of multicentre randomized controlled trial.
Bulava A, Wichterle D, Mokráček A, Osmančík P, Budera P, Kačer P, Vetešková L, Němec P, Skála T, Šantavý P, Chovančík J, Branny P, Rizov V, Kolesár M, Šafaříková I, Rybář M; SURHYB Trial Investigators. Bulava A, et al. Among authors: chovancik j. Europace. 2024 Feb 1;26(2):euae040. doi: 10.1093/europace/euae040. Europace. 2024. PMID: 38306687 Free PMC article. Clinical Trial.
Sequential hybrid ablation versus surgical CryoMaze alone for treatment of atrial fibrillation (SurHyb Trial): a protocol of the multicentre randomized controlled trial.
Bulava A, Mokracek A, Wichterle D, Budera P, Osmancik P, Kacer P, Veteskova L, Nemec P, Skala T, Santavy P, Chovancik J, Branny P, Rizov V, Kolesar M, Rybar M. Bulava A, et al. Among authors: chovancik j. J Appl Biomed. 2023 Jun;21(2):67-72. doi: 10.32725/jab.2023.007. Epub 2023 May 11. J Appl Biomed. 2023. PMID: 37212155 Free article.
Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).
Osmancik P, Havránek Š, Bulková V, Chovančík J, Roubíček T, Heřman D, Čarná Z, Tuka V, Matoulek M, Fiala M, Jiravský O, Stregl-Hruskova S, Latiňák A, Kotryová J, Jarkovský J. Osmancik P, et al. Among authors: chovancik j. BMJ Open. 2022 Jun 15;12(6):e056522. doi: 10.1136/bmjopen-2021-056522. BMJ Open. 2022. PMID: 35705334 Free PMC article.
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial.
Branny M, Osmancik P, Kala P, Poloczek M, Herman D, Neuzil P, Hala P, Taborsky M, Stasek J, Haman L, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Peichl P, Tousek P, Hozman M, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY; PRAGUE-17 Trial Investigators. Branny M, et al. Among authors: chovancik j. J Cardiovasc Electrophysiol. 2023 Sep;34(9):1885-1895. doi: 10.1111/jce.16029. Epub 2023 Aug 2. J Cardiovasc Electrophysiol. 2023. PMID: 37529864 Clinical Trial.
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY; PRAGUE-17 Trial Investigators. Osmancik P, et al. Among authors: chovancik j. J Am Coll Cardiol. 2020 Jun 30;75(25):3122-3135. doi: 10.1016/j.jacc.2020.04.067. J Am Coll Cardiol. 2020. PMID: 32586585 Free article. Clinical Trial.
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY; PRAGUE-17 Trial Investigators. Osmancik P, et al. Among authors: chovancik j. J Am Coll Cardiol. 2022 Jan 4;79(1):1-14. doi: 10.1016/j.jacc.2021.10.023. Epub 2021 Nov 5. J Am Coll Cardiol. 2022. PMID: 34748929 Free article. Clinical Trial.
Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study.
Fiala M, Chovancík J, Nevralová R, Neuwirth R, Jiravský O, Nykl I, Sknouril L, Dorda M, Januska J, Branny M. Fiala M, et al. Among authors: chovancik j. J Interv Card Electrophysiol. 2008 Jun;22(1):13-21. doi: 10.1007/s10840-008-9212-7. Epub 2008 Apr 17. J Interv Card Electrophysiol. 2008. PMID: 18418704 Clinical Trial.
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study).
Osmancik P, Tousek P, Herman D, Neuzil P, Hala P, Stasek J, Haman L, Kala P, Poloczek M, Branny M, Chovancik J, Cervinka P, Holy J, Vancura V, Rokyta R, Taborsky M, Kovarnik T, Zemanek D, Peichl P, Haskova S, Jarkovsky J, Widimsky P; PRAGUE-17 Investigators. Osmancik P, et al. Among authors: chovancik j. Am Heart J. 2017 Jan;183:108-114. doi: 10.1016/j.ahj.2016.10.003. Epub 2016 Oct 11. Am Heart J. 2017. PMID: 27979034 Clinical Trial.
28 results